People. Progressive. Principled

News

Tepnel Pharma Services expands its Analytical Capabilities

Tepnel’s ICH stability and Batch Release testing capability are the core testing activities within the Livingston site and assists partners from around the world in delivering first class medicines that improve patient outcomes. The Livingston site now offers Capillary Electrophoresis in an ongoing commitment to deliver the various different approaches to quantifying formulation stability and … Continued

Life Sciences Strategy for Scotland – 2025 Vision

Tepnel Pharma Services is an active member of the Scottish Life Sciences community promoting our wealth or scientific companies, academic institutions and a healthcare service that is world class. We look forward to the strategy refresh which sets a blue print for how our community will work together to promote the economic contribution of the … Continued

Tepnel Pharma Services presenting and exhibiting at 2016 Biotech Outsourcing Strategies CMC Conference June 28th and 29th, 2016 in Basel.

Tepnel Pharma Services will be attending the 2016 Biotech Outsourcing Strategies CMC Conference in Basel this month. BOS CMC is a leading partnering event for the CMC outsourcing community and Tepnel will be joining guest speaker, Kate Vitasek, a global authority on collaborative buyer/supplier partnerships, who is leading the Supplier Relationships module, to discuss Vested … Continued

Vested Outsourcing Business Approach on Stand 504 at 2016 AAPS National Biotechnology Conference

Tepnel Pharma Services, a division of Hologic, Inc. will be attending the 2016 AAPS National Biotechnology Conference in Boston this month.  We will be exhibiting at Stand 504 where you can speak to Dr Vikki Renwick or Dr Alex McDowell to see how you can achieve a better outsourcing relationship. The Vested Outsourcing model recognises … Continued

Hologic’s Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services

Manchester, England, 19 Jan. 2016 – Tepnel Pharma Services (Tepnel), a business unit of Hologic, Inc., announced today that it has been awarded ISO 17025:2005 accreditation for DNA extraction from whole blood using Nucleon chemistry and DNA genotyping using InvaderPLUS by the United Kingdom Accreditation Service (UKAS). This internationally recognised standard provides evidence of the … Continued

Tepnel Pharma Services to Introduce an Expanded Portfolio of Services at CPhI 2013 Stand no: 42B13

Tepnel Pharma Services, part of Hologic, Inc. (Hologic or the Company), will introduce an expanded portfolio of regulatory compliant analytical services at CPhI 2013 (Convention of Pharmaceutical Ingredients). Two new analytical offerings will be introduced at the convention: Global Batch and Lot Release Service for manufacturers of proprietary bio/pharmaceuticals based outside of the European Union … Continued

Tepnel Pharma Services to offer Proprietary Hologic Invader Chemistry

Tepnel Pharma Services, a division of Hologic, Inc. (Hologic or the Company), is now using Hologic’s proprietary Invader and Invader Plus technology as part of its Molecular Genetic Services offering, enabling it to offer customers a more cost effective and high throughput genotyping and copy number variation (CNV) service. The Invader chemistry platform is a … Continued

Tepnel Pharma Services Achieves Certification for Ion Torrent PGM Sequencing

Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that its subsidiary, Tepnel Pharma Services (Tepnel), has successfully achieved authorised customer service provider (CSP) status in the Ion Torrent Service … Continued

Tepnel Pharma Services expands portfolio to include Companion Diagnostic Development

Tepnel Pharma Services (Tepnel), a business unit of Hologic, Inc., has expanded its portfolio of services to include companion diagnostic development, the company announced today. The companion diagnostic development service will build on Tepnel’s reputation as a world class contract research organization specializing in molecular genetic services. The growth in companion diagnostic development has been … Continued

Tepnel Pharma Services becomes Authorised Affymetrix Service Provider – Launches OncoScan® FFPE Service

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that Tepnel Pharma Services (Tepnel), a subsidiary of Hologic, has become an authorised Affymetrix Service Provider and has launched the Affymetrix OncoScan FFPE Service. Tepnel’s … Continued

All About us

Latest Tweets